+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Orthopedic Implants Market by Product Type, Biomaterial, and Type: Global Opportunity Analysis and Industry Forecast, 2018 - 2025

  • ID: 4828502
  • Report
  • Region: Global
  • 310 pages
  • Allied Analytics LLP
1 of 4
The orthopedic implants market accounted for $45,901 million in 2017 is expected to reach $66,636 million by 2025, registering a CAGR of 4.7% from 2018 to 2025.

Orthopedic implants are medical devices that are used to replace or provide support to damaged bones or joints. These are fabricated using stainless steel and titanium alloys for strength, with plastic coating that acts as an artificial cartilage. These implants are applicable in orthopedic injuries, treatment of several types of arthritis, fractures etc. Orthopedic implants also useful in the joint replacement surgery, which is performed to remove the damaged joint and replace it with a new joint, called prosthesis. The remarkable shift from traditional invasive procedures to minimal invasive surgeries has positively impacted the market growth.

Major factors such as rise in prevalence of orthopedic injuries or diseases and rapid increase in the aging population globally drive the market. In addition, technological innovations in the orthopedic implants industry, acceptance for implantable medical devices, and improvement of healthcare infrastructure in the emerging countries further supplement the market growth. However, high cost associated with procedures involving orthopedic implants treatment and stringent government policies hamper the market growth. Furthermore, the emerging economies present lucrative opportunities to the market.

This report segments the orthopedic implants market on the basis of product type, type, material type, and region to provide a detailed assessment of the market. Based on product type, the market is divided into reconstructive joint replacements, spinal implants, dental implants, trauma, orthobiologics and others. On the basis of type, the market is segmented into knee, hip, wrist & shoulder, dental, spine, ankle, and others. Depending on material type, it is differentiated into metallic biomaterials, ceramic biomaterials, polymers biomaterials, and others. The metallic biomaterials is further segmented into stainless steel, titanium alloy, cobalt alloy, and others.

Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

KEY MARKET BENEFITS
  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2017 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
  • A comprehensive analysis of all the regions is provided to determine the existing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS

BY Product Type
o Reconstructive Joint Replacements
Knee Replacement Implants
Hip Replacement Implants
Extremities
o Upper Extremity
Shoulder
Elbow
Wrist
o Lower Extremity
Upper
Lower
o Spinal Implants
Spinal Fusion Devices
  • Thoracolumbar Devices
  • Cervical Fixation Devices
  • Interbody Fusion Devices
Vertebral Compression Fracture (VCF) Devices
  • Balloon Kyphoplasty Devices
  • Vertebroplasty Devices
Motion Preservation Devices/Non-Fusion Devices
  • Dynamic Stabilization Devices
  • Artificial Disc Replacement Devices
  • Annulus Repair Devices
  • Nuclear Disc Prostheses
Invasive Spinal Bone Stimulators
o Dental Implants
Root Form Dental Implants
Plate Form Dental Implants
o Trauma
o Orthobiologics
Demineralized Bone Matrix (DBM)
Allograft
Bone Morphogenetic Protein (BMP)
Viscosupplementation Products
Synthetic Bone Substitutes
Others
o Others

By Biomaterial
o Metallic Biomaterials
  • Stainless steel
  • Titanium Alloy
  • Cobalt Alloy
  • Others
o Polymeric Biomaterials
o Ceramic Biomaterials
o Others

By Type
o Knee
o Hip
o Wrist & Shoulder
o Dental
o Spine
o Ankle
o Others

By Geography
o North America
U.S.
Canada
Mexico
o Europe
Germany
France
UK
Italy
Spain
Rest of Europe
o Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
o LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

KEY PLAYERS PROFILED
o Arthrex, Inc.
o Conmed Corporation
o DJO Finance LLC
o Globus Medical, Inc.
o Johnson & Johnson (DePuy Synthes)
o Medtronic plc.
o Stryker Corporation
o Smith and Nephew plc.
o Wright Medical Group N.V.
o Zimmer Biomet Holdings, Inc.

The other players in the value chain include (profiles not included in the report)
  • NuVasive, Inc.
  • Synthes Holding AG
  • Arthrocare Corporation
  • Integra Lifesciences Holdings Corporation
  • Aesculap Implant Systems
  • The Orthopedic Implant Company
  • BioTek Instruments, Inc.
Note: Product cover images may vary from those shown
2 of 4
Chapter: 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. RESEARCH METHODOLOGY
1.2.1. Secondary research
1.2.2. Primary research
1.2.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.3. Market share analysis, 2016
3.3. PORTER’S FIVE FORCES ANALYSIS
3.3.1. Bargaining power of buyers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Competitive rivalry
3.4. CLINICAL TRIALS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.1.1. Rise in incidence of orthopedic diseases coupled with growing ageing population
3.5.1.2. Technological advancements in the field of orthopedic implants
3.5.1.3. Global rise in acceptance of orthopedic implants
3.5.1.4. Improved healthcare facilities in developing countries
3.5.2. Restraints
3.5.2.1. High cost of treatment associated with orthopedic implants procedures
3.5.2.2. Stringent approval process as these are highly specialized devices
3.5.3. Opportunities
3.5.3.1. Huge market opportunities in the developing countries

Chapter: 4 GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. RECONSTRUCTIVE JOINT REPLACEMENTS
4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Knee replacement implants
4.2.4.1. Market size and forecast
4.2.5. Hip replacement implants
4.2.5.1. Market size and forecast
4.2.6. Extremities
4.2.6.1. Market size and forecast
4.2.6.2. Upper extremity reconstruction
4.2.6.2.1. Market size and forecast
4.2.6.2.2. Shoulder reconstruction
4.2.6.2.2.1. Market size and forecast
4.2.6.2.3. Elbow reconstruction
4.2.6.2.3.1. Market size and forecast
4.2.6.2.4. Hand & wrist
4.2.6.2.4.1. Market size and forecast
4.2.6.3. Lower extremity reconstruction
4.2.6.3.1. Market size and forecast
4.2.6.3.2. Foot reconstruction
4.2.6.3.2.1. Market size and forecast
4.2.6.3.3. Ankle reconstruction
4.2.6.3.3.1. Market size and forecast
4.3. SPINAL IMPLANTS
4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Spinal fusion devices
4.3.4.1. Market size and forecast
4.3.4.2. Thoracolumbar devices
4.3.4.2.1. Market size and forecast
4.3.4.3. Cervical fixation devices
4.3.4.3.1. Market size and forecast
4.3.4.4. Interbody fusion devices
4.3.4.4.1. Market size and forecast
4.3.5. Motion preservation devices
4.3.5.1. Market size and forecast
4.3.5.2. Dynamic stabilization devices
4.3.5.2.1. Market size and forecast
4.3.5.3. Artificial discs
4.3.5.3.1. Market size and forecast
4.3.5.4. Annulus repair devices
4.3.5.4.1. Market size and forecast
4.3.5.5. Nuclear disc prostheses
4.3.5.5.1. Market size and forecast
4.3.6. Vertebral compression fracture (vcf) treatment devices
4.3.6.1. Market size and forecast
4.3.6.2. Balloon kyphoplasty devices
4.3.6.2.1. Market size and forecast
4.3.6.3. Vertebroplasty devices
4.3.6.3.1. Market size and forecast
4.3.7. Invasive spinal bone stimulators
4.3.7.1. Market size and forecast
4.4. DENTAL IMPLANTS
4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. Root form dental implants
4.4.4.1. Market size and forecast
4.4.5. Plate form dental implants
4.4.5.1. Market size and forecast
4.5. ORTHOBIOLOGICS
4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast
4.5.4. Allografts
4.5.4.1. Market size and forecast
4.5.4.2. Machined allograft
4.5.4.2.1. Market size and forecast
4.5.4.3. Demineralized bone matrix (dbm)
4.5.4.3.1. Market size and forecast
4.5.5. Bone graft substitutes
4.5.5.1. Market size and forecast
4.5.5.2. Bone morphogenic proteins (bmp)
4.5.5.2.1. Market size and forecast
4.5.5.3. Synthetic bone grafts
4.5.5.3.1. Market size and forecast
4.5.6. Cell based matrices (cbm)
4.5.6.1. Market size and forecast
4.6. TRAUMA & CRANIOMAXILLOFACIAL
4.6.1. Key market trends
4.6.2. Key growth factors and opportunities
4.6.3. Market size and forecast
4.6.4. Screw
4.6.4.1. Market size and forecast
4.6.5. Plates
4.6.5.1. Market size and forecast
4.6.6. Staples
4.6.6.1. Market size and forecast
4.6.7. Others
4.6.7.1. Market size and forecast
4.7. OTHERS
4.7.1. Key market trends
4.7.2. Growth factors and opportunities
4.7.3. Market size and forecast

Chapter: 5 GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. CERAMICS BIOMATERIALS
5.2.1. Market size and forecast
5.3. METALLIC BIOMATERIALS
5.3.1. Market size and forecast
5.4. POLYMERIC BIOMATERIALS
5.4.1. Market size and forecast
5.5. NATURAL BIOMATERIALS
5.5.1. Market size and forecast

Chapter: 6 GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY GEOGRAPHY
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast by country
6.2.4. Market size and forecast by Product
6.2.5. Market size and forecast by Biomaterial
6.2.5.1. U.S. market size and forecast
6.2.5.2. Canada market size and forecast
6.2.5.3. Mexico market size and forecast
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast by country
6.3.4. Market size and forecast by Product
6.3.5. Market size and forecast by Biomaterial
6.3.5.1. Germany market size and forecast
6.3.5.2. France market size and forecast
6.3.5.3. UK market size and forecast
6.3.5.4. Rest of Europe market size and forecast
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast by country
6.4.4. Market size and forecast by Product
6.4.5. Market size and forecast by Biomaterial
6.4.5.1. Japan market size and forecast
6.4.5.2. China market size and forecast
6.4.5.3. India market size and forecast
6.4.5.4. Rest of Asia-Pacific market size and forecast
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast by country
6.5.4. Market size and forecast by Product
6.5.5. Market size and forecast by Biomaterial
6.5.5.1. Latin America market size and forecast
6.5.5.2. Africa market size and forecast
6.5.5.3. Middle East market size and forecast

Chapter: 7 COMPANY PROFILES
7.1. AESCULAP IMPLANT SYSTEMS
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Product portfolio
7.1.4. Key strategic moves and developments
7.2. B. BRAUN MELSUNGEN AG (AESCULAP AG)
7.2.1. Company overview
7.2.2. Company Snapshot
7.2.3. Operating business segments
7.2.4. Business performance
7.2.5. Key strategic moves and developments
7.3. BIOTRONIK SE & CO. KG
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Key strategic moves and developments
7.4. CONMED CORPORATION
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments
7.5. GLOBUS MEDICAL, INC.
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating product categories
7.5.4. Business performance
7.5.5. Key strategic moves and developments, 2014-2016
7.6. JOHNSON & JOHNSON
7.6.1. Company overview
7.6.2. Company Snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.6.6. Key strategic moves and developments
7.7. MEDTRONIC PLC
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments
7.8. SMITH & NEPHEW PLC.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. STRYKER CORPORATION
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.9.6. Key strategic moves and developments
7.9.7. Operating Business Segments
7.9.8. Business performance
7.9.9. Key strategic moves and developments
7.10. ZIMMER BIOMET HOLDINGS, INC.
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating product categories
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments

*Full List of Tables and Figures Available on Enquiry.

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
According to this report titled 'Orthopedic Implants Market by Product, Type and Biomaterials: Global Opportunity Analysis and Industry Forecast, 2017 - 2025', the orthopedic implants market size was valued at $45,901 million in 2017, and is projected to reach $66,636 million by 2025, growing at a CAGR of 4.7% from 2018 to 2025.

Orthopedic implant is a medical device surgically placed inside the body to restore bone function by reinforcing or replacing a damaged structure. These implants are either permanently incorporated inside the human body or withdrawn after desired results. The growth in number of replacement surgeries, such as knee, hip, shoulder, and other (bone or joint) has propelled the demand for implants globally.

Factors that drive the growth of the global orthopedic implants market are rise in prevalence of orthopedic injuries or diseases and the rapid rise in geriatric population. In addition, technological innovations, such as robot-assisted surgical tools, acceptance for implantable medical devices, and widespread application of orthopedic implants to treat musculoskeletal, orthopedic diseases, & injuries further supplement the market growth. However, high cost associated with procedures involving orthopedic implants for treatment and stringent government policies hamper the market growth. Furthermore, the emerging economies present lucrative opportunities for the market.

On the basis of product type, the reconstructive joint replacements segment is estimated to garner largest share during the forecast period. This segment is expected to maintain its dominant position throughout the analysis period, owing to rise in prevalence of osteoporosis and osteoarthritis, and investment of key players in R&D of orthopedic implants. On the other side, the orthobiologics is the fastest growing segment during the forecast period owing to the rise in demand for advanced therapies, minimally invasive procedures, and surge in patient awareness toward use of orthobiologics.

According to type, the knee segment accounted for the highest orthopedic implant market share in 2017, and is anticipated to maintain this trend during the forecast period. However, spine is estimated to register the highest CAGR during the forecast period attributed to increase in geriatric population, rise in incidence of spinal disorders, and expansion in the indications for which spinal fusion surgery is performed.
By material type, the metallic biomaterials segment occupied the largest share in 2017, owing to cost-effectiveness of these materials. Metallic biomaterials provide efficacy of bone healing as compared to other materials. These are used to manufacture various orthopedic implants such as screws, plates, vertebral compression fracture (VCF) devices, and others. However, other biomaterials are estimated to register the highest CAGR during the forecast period. This is due to the growing demand for these materials owing to their several advantages over synthetic biomaterials. These advantages include biocompatibility, no toxicity, and may also carry specific protein binding sites, and other biochemical signals that can help in the process of tissue healing or integration.

Key Findings of the Orthopedic Implants Market:

The orthobiologics segment is anticipated to grow at a highest rate during the forecast period.
U.S. was the major shareholder in the North America orthopedic implants market, accounting for more than three-fourths share in 2017.
The metallic segment occupied about 64.85% share of the total biomaterial market in 2017.
China occupied about one-third share of the total Asia-Pacific orthopedic implants market in 2017.
The knee segment accounted approximately one-fourth share of the orthopedic implants market in 2017.

In 2017, Asia-Pacific and LAMEA collectively accounted for more than one-fourth of the total orthopedic implants industry and are expected to continue this trend due to increase in implants development, specifically in China, India, and the other developing countries. Factors such as rise in buying power with developing healthcare infrastructure, and increase in geriatric population, fuel the growth of the orthopedic implants market in the Asia-Pacific region.

The major companies profiled in this report include Johnson & Johnson (DePuy Synthes), Zimmer Biomet Holdings, Inc., Stryker Corporation, Medtronic Plc, and Smith and Nephew Plc., Wright Medical Group N.V., CONMED Corporation., Arthrex, Inc., DJO Finance LLC, and Globus Medical Inc.
Note: Product cover images may vary from those shown
5 of 4

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll